Sage Journals: Discover world-class research

Retricted access

Research article

First published 2026

“The opportunity was there”: Applying Routine Activity Theory to relapse into substance use

Nili Gesser, Hayley Wight

Criminology & Criminal Justice

Retricted access

Research article

First published 1998-06

In vitro cytokine profiles as indicators of relapse activity and clinical course in multiple sclerosis

Myriam Schluep, Guy van Melle, Hugues Henry [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2025-4

Quality of life is decreased in persons with relapsing-remitting multiple sclerosis experiencing progression independent of relapse activity

Sarah Lindberg, Sofia Sandgren, Markus Axelsson [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2024-10

The time to include cognition in the multiple sclerosis concept of progression independent from relapse activity is now

Stefano Ziccardi, Maddalena Guandalini, Tom A Fuchs [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2018-1

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a

Eva Havrdová, Douglas L Arnold, Amit Bar-Or [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Other

First published 2009-11

Severe relapses after the first infusion of natalizumab in active relapsing—remitting multiple sclerosis

Francesca Rinaldi, Paola Perini, Massimiliano Calabrese [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2025-7

Relapse or no relapse in multiple sclerosis: Can disease activity biomarkers support the clinician?

Jeske van Pamelen, Marleen J A Koel-Simmelink, Birgit I Lissenberg [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2017-11

No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study

Ludwig Kappos, Eva Havrdova, Gavin Giovannoni [...]

Multiple Sclerosis Journal

Open access

Review article

First published 2015-1

Alemtuzumab: A new therapy for active relapsing–remitting multiple sclerosis

Hans-Peter Hartung, Orhan Aktas, Alexey N Boyko

Multiple Sclerosis Journal

Retricted access

Research article

First published 2015-6

Nrf2 Activation Attenuates Both Orthodontic Tooth Movement and Relapse

H. Kanzaki, F. Shinohara, K. Itohiya-Kasuya [...]

Journal of Dental Research

Search results